Replies to post #205034 on Anavex Life Sciences Corp (AVXL)

[Reyeton]

And if it restores gut biome diversity, why wouldn’t 2-73 be included to supplement and possibly improve the pharmakinetics of drugs used to treat other diseases?

[nidan7500]

Xena...

If 2-73 helps to restore homeostasis in the gut that strengthens the argument that the MOA will have an effect on most (if not all) CNS diseases (and perhaps diseases of the heart, liver, etc

I was looking for more/better trials/data/date information so I am not happy that he was not more specific. M. did convey a sense of urgency about getting trial data in late 2019 (in our lifetime) and he did so w/legitimate enthusiasm. After long periods of dark I also see a drive to get things done. Of course, we have the FDA and others who could give a shat less, to deal with. Wouldn't it be nice to get the system pulling w/us? Begin operation send mail to WH.

We are going to have to make this happen in spite of the current trials system. We may see some the WS herd start to listen up. Links to gut microbiome research will start to show up as momentum builds. Eventually it is too big to ignore. The science will take us where it will but we are in the left seat. This is not a drill.